|Articles|July 5, 2018
Improving Provider and Patient Acceptance of Biosimilars in Treating Cancer
https://www.pharmacytimes.org/on-demand/biosimilars-in-treating-cancer
Advertisement
https://www.pharmacytimes.org/on-demand/biosimilars-in-treating-cancer
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making
4
Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD
5
